MetaCap

Nature's Sunshine Products Inc. (NATR)

NASDAQ: NATRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.18+0.01 (+0.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NATR stock chart

Technical analysis

Key statistics

All statistics
Market cap
$176.41M
Ex-dividend date
Mar 26, 2021
52-week range
9.38 – 28.14
Day range
10.05 – 10.35
Volume / Avg
318.11K / 168.24K
Beta
—

52-week range

$9.38$28.14

NATR stock today

On Nov 20, NATR ended the session at $10.18, adding $0.01 (0.10%), versus the S&P 500's 3.70% decline. Shares are 63.8% below their 52-week high of $28.14, set on Mar 2, 2026 and 8.5% above the 52-week low of $9.38, near the bottom of the past year's range. NATR is down 52.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 51.8%.

Nature's Sunshine Products trades at 12.4x its trailing twelve-month earnings per share of $0.82. Its forward P/E of 10.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Nature's Sunshine Products

Company profile

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Kenneth G. Romanzi
Headquarters
Lehi, UT
Employees
806

Financial highlights

Full financials

In fiscal 2025, Nature's Sunshine Products generated $480.1 million in revenue, up 5.7% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $19.5 million (+153.7% year over year), for a net margin of 4.1% versus a median of 3.4% in the prior 5 years. Gross margin was 72.4% (up from 71.5%) and operating margin 5.2%.

Nature's Sunshine Products annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$480.14M$454.36M$445.32M$421.91M$444.08M
Growth+5.67%+2.03%+5.55%-4.99%+15.29%
Net income$19.52M$7.70M$15.08M$-390.00K$30.21M
EPS (diluted)$1.06$0.40$0.77$-0.02$1.42

Analyst forecast

Forecast

Consensus (2 analysts)

strong_buy

Avg. price target

$16.50+62.08%

  • Strong buy 0
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $12.00High $21.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.11 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$1.00
Ex-dividend date
Mar 26, 2021

NATR news

All NATR news

Nature's Sunshine Products peers

Health Care sector
NATR peer companies
CompanyPrice% ChgMarket capCompare
VOGXVogenx Inc11.87-7.30%$176.33Mvs NATR
SIGASIGA Technologies Inc.2.40-9.43%$172.45Mvs NATR
ADCTADC Therapeutics SA1.28-1.54%$180.05Mvs NATR
SLGLSol-Gel Technologies Ltd.55.17+2.02%$180.63Mvs NATR
WHWKWhitehawk Therapeutics Inc.3.07-1.60%$181.16Mvs NATR
TRDAEntrada Therapeutics Inc.4.35-6.25%$170.30Mvs NATR
KRROKorro Bio Inc.12.18-0.08%$167.18Mvs NATR
ABEOAbeona Therapeutics Inc.2.42-1.22%$165.31Mvs NATR

Indexes, lists and sector

Nature's Sunshine Products stock FAQ

What is Nature's Sunshine Products's stock price today?

NATR last traded at $10.18 as of Nov 20, 4:00 PM EST, up 0.10% on the day. Prices are delayed at least 15 minutes.

Does Nature's Sunshine Products pay a dividend?

Yes. Nature's Sunshine Products pays $0.00 per share annually. The most recent dividend of $1.00 had an ex-dividend date of Mar 26, 2021.

What is NATR's P/E ratio?

NATR trades at a trailing P/E ratio of 12.41 and a forward P/E of 10.77.

Who is Nature's Sunshine Products's CEO?

Mr. Kenneth G. Romanzi is the chief executive officer of Nature's Sunshine Products Inc., which has about 806 employees.

What is the NATR 52-week high?

The 52-week high for NATR is $28.14 and the 52-week low is $9.38. The stock is currently 63.8% below its high.

Compare NATR